V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 300005083 | 300003467 | 1.5 | 145.1 | Palliative (P) | 2015-09-20 | 2016-05-22 | GemCarbo Days 1+8 | N | N | 300008281 | FLUOROURACIL + MITOMYCIN |
| 300005084 | 300008010 | 0 | 62.1 | Curative (C) | 2015-06-04 | 2015-06-28 | ESPAC-4 TRIAL | 2 | Y | 300008441 | GEMCARBO |
| 300005085 | 300008010 | 1.75 | 77.6 | Palliative (P) | 2017-09-11 | 2017-10-07 | ECX | 02 | N | 300008441 | CARBOPLATIN |
| 300005086 | 300008314 | null | 72 | Palliative (P) | 2017-10-20 | 2017-10-22 | Fluorouracil+Mitomycin+RT (Anal Ca) | 02 | null | 300008491 | CARBOPLATIN + ETOPOSIDE |
| 300005087 | 300003468 | null | 94.8 | Palliative (P) | 2018-08-19 | 2018-09-07 | Capecitabine + Cisplatin | N | N | 300008495 | TEMOZOLOMIDE |
| 300005088 | 300006291 | 1.63 | 85.9 | Palliative (P) | 2018-11-15 | 2018-11-15 | GemCarbo Days 1+8 | 02 | N | 300008539 | GEMCARBO |
| 300005089 | 300003469 | 1.68 | 64.6 | Palliative (P) | 2015-12-25 | 2016-01-24 | Carboplatin + Docetaxel | 02 | N | 300008609 | GEMCARBO |
| 300005090 | 300003469 | 1.71 | 62 | Palliative (P) | 2018-08-06 | 2018-08-10 | Carboplatin + Etoposide iv&po | N | N | 300008609 | ECX |
| 300005091 | 300003470 | 1.5 | 66.3 | Palliative (P) | 2016-06-05 | 2016-07-06 | ESPAC-4 TRIAL | Y | N | 300008841 | GEMCARBO |
| 300005092 | 300003470 | 1.41 | 57.7 | Palliative (P) | 2019-02-17 | 2019-02-27 | Carboplatin AUC 6 - 10 | 02 | N | 300008841 | GEMCARBO |
| 300005093 | 300003471 | 1.78 | 86.1 | Adjuvant (A) | 2015-11-19 | 2015-11-29 | GemCarbo Days 1+8 | 02 | N | 300008989 | CETUXIMAB + CISPLATIN + FU |
| 300005094 | 300003471 | null | 0 | Palliative (P) | 2014-12-14 | 2014-12-21 | TCF | 02 | N | 300008989 | CISPLATIN + ETOPOSIDE |
| 300005095 | 300003472 | 1.55 | null | Curative (C) | 2017-11-29 | 2017-11-30 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | 300009034 | CAPECITABINE + MITOMYCIN + RT |
| 300005096 | 300003472 | 1.61 | 91.5 | Curative (C) | 2018-06-01 | 2018-06-21 | ECX | 02 | N | 300009034 | ESPAC TRIAL |
| 300005097 | 300007535 | 1.64 | 61 | Curative (C) | 2016-08-17 | 2016-08-22 | Carboplatin + Etoposide IV 3 day | N | N | 300009058 | CAPECITABINE + CISPLATIN |
| 300005098 | 300003473 | 1.61 | 53.9 | null | 2016-08-12 | 2016-08-25 | Rituximab | 01 | null | 300009181 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 300005099 | 300003474 | 1.64 | null | Palliative (P) | 2017-07-28 | 2017-07-28 | Carboplatin + Etoposide iv&po | 2 | null | 300009300 | HYDROXYCARBAMIDE |
| 300005100 | 300003475 | null | 0 | Palliative (P) | 2017-03-14 | 2017-03-20 | CARBOPLATIN + GEMCITABINE | 1 | N | 300009512 | CARBOPLATIN + CETUXIMAB + FU |
| 300005101 | 300003476 | 1.65 | 90 | Palliative (P) | 2017-12-21 | 2017-12-22 | Gemcitabine + Capecitabine | Y | N | 300009515 | MAESTRO TRIAL |
| 300005102 | 300003477 | 1.8 | null | Curative (C) | 2017-01-16 | 2017-01-19 | CARBOPLATIN + RT | N | N | 300009703 | COMPARE TRIAL |
| 300005103 | 300003477 | 1.49 | 55.1 | Palliative (P) | 2016-11-18 | 2016-12-05 | Carboplatin + Etoposide iv&po | 02 | N | 300009703 | DABRAFENIB |
| 300005104 | 300003478 | 1.79 | null | null | 2017-06-08 | 2017-07-04 | Gemcitabine + Capecitabine | N | Y | 300009901 | DOCETAXEL |
| 300005105 | 300003479 | 1.55 | 112.1 | Adjuvant (A) | 2015-11-24 | 2015-12-04 | CARBOPLATIN + RT | 02 | N | 300009937 | IMATINIB |
| 300005106 | 300003480 | 1.59 | 80.5 | Curative (C) | 2015-06-28 | 2015-06-28 | CARBOPLATIN + GEMCITABINE | 02 | N | 300009971 | CAPECITABINE + GEMCITABINE |
| 300005107 | 300006297 | 1.58 | 68.4 | Palliative (P) | 2016-09-20 | 2016-10-10 | PEMBROLIZUMAB | 2 | N | 300010048 | FLUOROURACIL + MITOMYCIN |
| 300005108 | 300006297 | 1.7 | 137 | Palliative (P) | 2017-02-06 | 2017-02-20 | Carboplatin+Fluorouracil 4 or 5 day | 02 | N | 300010048 | CISPLATIN + ETOPOSIDE |
| 300005109 | 300003481 | null | 73.2 | Palliative (P) | 2019-02-09 | 2019-03-16 | CHOP R | N | N | 300010106 | CARBOPLATIN + CETUXIMAB + FLUOROURACIL |
| 300005110 | 300003482 | 1.55 | null | Palliative (P) | 2017-07-10 | 2017-07-12 | Gemcitabine + Capecitabine | null | N | 300010197 | CARBOPLATIN |
| 300005111 | 300003483 | 1.72 | 53.9 | Adjuvant (A) | 2017-12-29 | 2017-12-31 | GEMCITABINE + NAB PACLITAXEL | 02 | N | 300010315 | NILOTINIB |
| 300005112 | 300003483 | null | 68 | Neo-adjuvant (N) | 2015-02-07 | 2015-02-07 | CISPLATIN + VINORELBINE | 2 | N | 300010315 | CISPLATIN + FLUOROURACIL + RT |
| 300005113 | 300003483 | 1.73 | 85.1 | Palliative (P) | null | 2017-07-01 | CAPECITABINE + RT | N | N | 300010315 | DABRAFENIB |
| 300005114 | 300003484 | 1.7 | null | Curative (C) | 2015-05-27 | 2015-06-03 | EC | 02 | Y | 300010643 | ACTICCA-1 TRIAL |
| 300005115 | 300003484 | 1.64 | 92.4 | Palliative (P) | 2016-03-10 | 2016-03-26 | CHOP R | 2 | N | 300010643 | EOX |
| 300005116 | 300003485 | 1.63 | 74.5 | Curative (C) | 2016-02-27 | 2016-03-08 | CAPECITABINE + MITOMYCIN + RT | N | N | 300010901 | CAPECITABINE + CISPLATIN |
| 300005117 | 300003485 | 1.69 | 58.4 | Adjuvant (A) | 2019-02-14 | 2019-02-14 | IPILIMUMAB + NIVOLUMAB | 2 | N | 300010901 | CAPECITABINE + OXALIPLATIN |
| 300005118 | 300003486 | 1.55 | 55.1 | Curative (C) | null | 2016-02-27 | GemCarbo Days 1+8 | null | null | 300011149 | FEC + DOCETAXEL |
| 300005119 | 300003486 | 1.75 | 75.6 | Disease modification (D) | 2018-01-19 | 2018-02-01 | CISPLATIN + ETOPOSIDE | N | N | 300011149 | FLUOROURACIL + MITOMYCIN + RT |
| 300005120 | 300003487 | 1.7 | 92.4 | Adjuvant (A) | 2017-09-20 | 2017-09-22 | GemCarbo Days 1+8 | n | Y | 300011224 | FLUOROURACIL + MITOMYCIN + RT |
| 300005121 | 300003487 | 1.59 | 79.9 | Palliative (P) | 2016-01-02 | 2016-01-23 | Fluorouracil + Folinic Acid (Mayo) | N | N | 300011224 | FEC + DOCETAXEL |
| 300005122 | 300003488 | 1.79 | 129.8 | Palliative (P) | 2016-08-14 | 2016-09-11 | Carboplatin + Etoposide iv&po | N | N | 300011347 | GEMCARBO |
| 300005123 | 300003489 | 1.75 | 77.3 | Curative (C) | 2017-08-21 | 2017-08-22 | CARBOPLATIN + RT | 02 | N | 300011351 | CAPECITABINE + OXALIPLATIN |
| 300005124 | 300003490 | 1.81 | 76.3 | Adjuvant (A) | 2018-04-06 | 2018-05-03 | Folfirinox | N | N | 300011591 | CARBOPLATIN |
| 300005125 | 300003491 | 1.7 | 78.2 | Palliative (P) | 2017-01-19 | 2017-01-28 | CAPECITABINE + GEMCITABINE | 02 | N | 300011708 | NOT MATCHED |
| 300005126 | 300003492 | 1.58 | 66.6 | null | null | 2018-07-04 | FLUOROURACIL + MITOMYCIN | N | null | 300011850 | CARBOPLATIN + ETOPOSIDE |
| 300005127 | 300003493 | 1.67 | 72.52 | Palliative (P) | 2015-07-18 | 2015-07-19 | GEMCITABINE + NAB PACLITAXEL | 01 | N | 300011852 | GEMCARBO |
| 300005128 | 300003494 | 1.71 | 73.7 | Palliative (P) | 2015-02-07 | 2015-02-17 | ESPAC-4 TRIAL | N | N | 300011918 | CAPECITABINE + IRINOTECAN |
| 300005129 | 300003494 | 1.65 | 67.9 | Palliative (P) | 2017-03-19 | 2017-03-23 | Folfirinox | N | N | 300011918 | CISPLATIN + FLUOROURACIL + RT |
| 300005130 | 300007538 | 1.56 | 91.3 | Adjuvant (A) | 2018-02-25 | 2018-02-26 | CARBOPLATIN + RT | 2 | N | 300012308 | CISPLATIN + FLUOROURACIL + RT |
| 300005131 | 300008011 | 1.81 | 42.3 | Palliative (P) | null | 2013-06-02 | CARBOPLATIN + CETUXIMAB + FU | N | N | 300012741 | CARBOPLATIN + DOCETAXEL + FLUOROURACIL |
| 300005132 | 300008011 | 1.64 | 0 | Palliative (P) | 2017-11-07 | 2017-11-07 | IPILIMUMAB + NIVOLUMAB | N | N | 300012741 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |